These Health Insurers Have Been Stealing from You for Over a Decade

This is a syndicated repost courtesy of Money Morning – We Make Investing Profitable. To view original, click here. Reposted with permission.

Remember those soaring profits that propelled the stocks of health insurers to record highs starting in 2013?

Like how UnitedHealth Group Inc. (NYSE: UNH) hit an all-time high in June 2013 and never looked back? From January 2013 to January 2016, UNH stock nearly tripled the performance of the Standard & Poor’s 500 Index.

Humana Inc. (NYSE: HUM) fared even better, hitting an all-time high in September 2013. In that same three-year period HUM stock more than quadrupled the gains in the S&P 500.

Turns out those same health insurers fattened their profits with a lot of help from a years-long strategy to defraud the Medicare Advantage program.

And since Medicare derives its funding from the government, these health insurers have essentially been stealing money from you, the U.S. taxpayer, for their own gain.

And gain they did, to the tune of billions …

“There Was No Way They Could Lose”

The poster child for this scheme is UnitedHealth Group, the nation’s largest insurer. And as the biggest provider of “Medicare Advantage” plans (nearly 4 million enrollees as of December 2016), UnitedHealth stood to benefit the most.

According to a U.S. Department of Justice lawsuit filed May 16, between 2010 and 2015 UnitedHealth siphoned off about $3 billion in taxpayer money by overbilling Medicare Advantage. But the pattern of overpayments dates back as far as 2006.

“As the nation’s largest Medicare Advantage organization, UHG received substantial overpayments based upon untruthful and inaccurate information about the health status of those enrolled in its plans,” said Acting U.S. Attorney for the Western District of New York James P. Kennedy Jr. in a Justice Department statement. “Such fraudulent spending of taxpayers’ dollars will not be tolerated.”

health insurers

The suit is based on the allegations of whistleblower Benjamin Poehling, a former finance director for UnitedHealth who worked there from 2002 to 2012.

“They’ve set up a perfect scheme here,” Poehling told The New York Times. “It was rigged so there was no way they could lose.”

UnitedHealth disputes any wrongdoing. A UNH spokesman told the Times that his company “complied with the government’s Medicare Advantage program rules,” while criticizing the policies of the Centers for Medicare and Medicaid Services (CMS) as “murky.”

Don’t Miss: Start Collecting a “Second Salary” with These Powerful Income Generators

UnitedHealth is the only insurer named in the suit, but the Justice Department is investigating several other leading insurers for the same kind of Medicare Advantage fraud.

A prior complaint, filed in 2011, listed Aetna Inc. (NYSE: AET) and Humana Inc. as defendants. Humana has the second-highest number of Medicare Advantage enrollees, 3.21 million.

Other health insurers could be caught in the Justice Department’s web through acquisitions of companies named in the 2011 complaint: Centene Corp. (NYSE: CNC) via its 2016 merger with HealthNet, and Cigna Corp. (NYSE: CI) through its 2011 acquisition of Bravo Health-parent HealthSpring.

That so many health insurance companies have come under scrutiny speaks to how easy it was to cheat the Medicare Advantage program – and steal more money out of taxpayer pockets.

Here’s what the insurers were doing…

How the Health Insurers Poached Your Tax Dollars

When Medicare Advantage was created 14 years ago, it made private health insurers like UnitedHealth middlemen between beneficiaries and the government.

Under Medicare Advantage, the government reimburses insurers a base rate for each member it enrolls. But certain medical conditions, or combinations of medical conditions, can increase the reimbursements. The idea was to prevent the insurers from targeting only the healthiest (and thus most profitable) prospects.

But the idea backfired. Paying extra for a variety of conditions created an incentive to exaggerate a member’s health problems to increase reimbursement rates.

Take, for example, a typical male beneficiary between the ages of 70 and 74. The base payment to an insurer for such a patient in Medicare Advantage is $3,866 per year. But tacking on health conditions can inflate the annual payment to multiples of that amount.

Obviously, many of the diagnoses given in the last 10 years were legitimate. But the insurers could game the system in subtle ways. A diagnosis of diabetes without complications adds $1,058 to the annual payment. But diabetes with complications adds triple that amount – $3,251.

The trick was finding the patients with conditions conducive to this scheme. And technology had the answer in Big Data.

The insurers used complex data-mining programs to identify patients with conditions that could be “enhanced” without raising government suspicion.

Staff would then examine the medical records in a process called “risk scoring,” in what amounted to a treasure hunt for profits at the government’s expense.

They’ve set up a perfect scheme here

If the process happened to show that a patient had an unsupported diagnosis, UNH was obligated to delete it. But since that would mean less money for UnitedHealth, the company disregarded such information.

The potential of this process –  the so-called “chart review program” – to fatten the company’s bottom line quickly became apparent…

“Let’s Turn on the Gas!”

UnitedHealth increased its efforts to sign up more Medicare Advantage customers while simultaneously increasing the number of patient records it reviewed each year.

From 2007 to 2015, UnitedHealth more than doubled its number of Medicare Advantage patients.


According to the Justice Department lawsuit, UnitedHealth reviewed 600,000 charts in 2006. The resulting “condition inflation” of added diagnosis codes produced $270 million in extra revenue.

By 2011, UNH was reviewing 1.5 million charts per year, increasing their reward to $426 million.

According to the Justice Department, the rapid increase in chart reviews was part of a concerted effort by management to squeeze more money out of the Medicare Advantage program.

The original complaint includes a memo from the chief financial officer of UnitedHealth’s Medicare & Retirement division, Jerry Knutson, to Jeff Dumcum of Ingenix, the UNH subsidiary doing the data screening that lays bare the company’s motives.

“Wanted to get together with you and discuss what we can do in the short term and long term to really go after the potential risk scoring you have consistently indicated is out there,” Knutson wrote in the Nov. 7, 2007, memo. “You mentioned vasculatory disease opportunities, screening opportunities, etc. with huge $ opportunities. Let’s turn on the gas!”

Knutson continues: “When we meet next on our steering committee, I’d like to see what it would take to add another $100M to our 2008 revenue from where we are. What would be doable? What resources would you need? What technology would you need?”

This annual revenue bonus from these efforts continued to grow as UnitedHealth perfected its chart review program, reaching $882 million by 2014.

Meanwhile, UNH stock was going on a tear…

UnitedHealth Stock Soars on Ill-Gotten Revenue

UnitedHealth stock has soared more than 450% since Jan. 1, 2010, nearly quadrupling the 117% gain of the Standard & Poor’s 500 index.

Over the last three years, with the chart review program in full gear, UNH stock has done even better, with gains of 128% – more than quadrupling the S&P 500’s 27.5% increase.

And keep in mind these massive gains have come despite cumulative losses of about $1 billion from the Obamacare exchanges over the past two years.

The question now is whether the government will prevail against UnitedHealth, and if so, what kind of penalty it can exact. The suit asks for triple damages and penalties but not a specific sum.

The stakes for this case are particularly high. How the UnitedHealth suit fares may well determine how the government will proceed against the health insurers named in the 2011 complaint.

But the government also might want to rethink its Medicare Advantage policies.

“CMS could do a lot to change the rules so it’s not so easy to get away with this stuff,” Timothy Layton, an assistant professor at Harvard Medical School who focuses on health insurers, told The New York Times. “What the insurers are doing is not socially valuable at all.”

To get full access to all Money Morning content, click here

About Money Morning: Money Morning gives you access to a team of ten market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and visitors become smarter, more confident investors.

Disclaimer: © 2017 Money Morning and Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201.

The post These Health Insurers Have Been Stealing from You for Over a Decade appeared first on Money Morning – We Make Investing Profitable.

Wall Street Examiner Disclosure:Lee Adler, The Wall Street Examiner reposts third party content with the permission of the publisher. I am a contractor for Money Map Press, publisher of Money Morning, Sure Money, and other information products. I curate posts here on the basis of whether they represent an interesting and logical point of view, that may or may not agree with my own views. Some of the content includes the original publisher's promotional messages. In some cases I receive promotional consideration on a contingent basis, when paid subscriptions result. The opinions expressed in these reposts are not those of the Wall Street Examiner or Lee Adler, unless authored by me, under my byline. No endorsement of third party content is either expressed or implied by posting the content. Do your own due diligence when considering the offerings of information providers.

Leave a Reply